NASDAQ:ICUI - ICU Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$234.08 +2.14 (+0.92 %)
(As of 12/10/2018 01:13 PM ET)
Previous Close$231.94
Today's Range$231.17 - $235.67
52-Week Range$208.35 - $321.70
Volume2,494 shs
Average Volume320,676 shs
Market Capitalization$4.75 billion
P/E Ratio42.07
Dividend YieldN/A
Beta0.63
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV solutions, such as normal salines, ringers, etc., which are used to replenish fluids and electrolytes; irrigation solutions to hydrate the wound, remove deep debris, assist with visual examination, to prevent infection, and improve healing; and nutritional solutions that feed vitamins, minerals, and other natural therapeutic substances directly into the blood stream. In addition, the company offers infusion pumps under the Plum 360, LifeCare PCA, SapphirePlus, and Sapphire names; Cogent 2-in-1 and LiDCO LX1 hemodynamic monitoring systems; CardioFlo hemodynamic monitoring sensors; TriOx PICC invasive venous oximetry sensors; SafeSet closed blood sampling and conservation systems; Transpac consumable blood pressure transducers; and Q2 Plus continuous cardiac output/oximetry systems. The company sells its products primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
Previous Symbol
CUSIP44930G10
Phone949-366-2183

Debt

Debt-to-Equity RatioN/A
Current Ratio4.51
Quick Ratio3.07

Price-To-Earnings

Trailing P/E Ratio42.07
Forward P/E Ratio30.16
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.29 billion
Price / Sales3.71
Cash Flow$9.1188 per share
Price / Cash Flow25.67
Book Value$59.52 per share
Price / Book3.93

Profitability

EPS (Most Recent Fiscal Year)$5.52
Net Income$68.64 million
Net Margins6.00%
Return on Equity15.20%
Return on Assets12.40%

Miscellaneous

Employees6,802
Outstanding Shares20,490,000
Market Cap$4.75 billion
OptionableOptionable

ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

How were ICU Medical's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) announced its quarterly earnings data on Thursday, November, 8th. The medical instruments supplier reported $1.85 EPS for the quarter, beating the Zacks' consensus estimate of $1.51 by $0.34. The medical instruments supplier had revenue of $327.20 million for the quarter, compared to the consensus estimate of $334.97 million. ICU Medical had a net margin of 6.00% and a return on equity of 15.20%. The firm's revenue was down 4.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.12 earnings per share. View ICU Medical's Earnings History.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for ICU Medical.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical updated its FY18 earnings guidance on Thursday, November, 8th. The company provided earnings per share guidance of $8.45-8.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.60. ICU Medical also updated its FY 2018 guidance to $8.45-8.85 EPS.

Has ICU Medical been receiving favorable news coverage?

Media stories about ICUI stock have been trending very positive on Monday, according to InfoTrie. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ICU Medical earned a news sentiment score of 3.9 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.

Who are some of ICU Medical's key competitors?

Who are ICU Medical's key executives?

ICU Medical's management team includes the folowing people:
  • Mr. Vivek Jain, Chairman & CEO (Age 46)
  • Mr. Scott E. Lamb, CFO & Treasurer (Age 55)
  • Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 60)
  • Ms. Alison D. Burcar, Corp. VP of Product Strategy for IV Consumables (Age 45)
  • Mr. Steven C. Riggs, Exec. Officer of Special Project Opertions (Age 59)

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.24%), BlackRock Inc. (6.99%), Janus Henderson Group PLC (6.70%), Wells Fargo & Company MN (2.48%), JPMorgan Chase & Co. (2.40%) and AQR Capital Management LLC (1.87%). Company insiders that own ICU Medical stock include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Pfizer Inc, Richard Md Sherman, Robert S Swinney, Scott E Lamb, Steven Riggs, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical.

Which institutional investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Dimensional Fund Advisors LP, Morgan Stanley, Teachers Advisors LLC, Castleark Management LLC, Royce & Associates LP, Eagle Asset Management Inc. and JPMorgan Chase & Co.. Company insiders that have sold ICU Medical company stock in the last year include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall and Virginia Ruth Sanzone. View Insider Buying and Selling for ICU Medical.

Which institutional investors are buying ICU Medical stock?

ICUI stock was bought by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Vanguard Group Inc., Marshall Wace LLP, TIAA CREF Investment Management LLC, Martingale Asset Management L P, BlackRock Inc., FMR LLC and American Century Companies Inc.. View Insider Buying and Selling for ICU Medical.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $232.89.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $4.75 billion and generates $1.29 billion in revenue each year. The medical instruments supplier earns $68.64 million in net income (profit) each year or $5.52 on an earnings per share basis. ICU Medical employs 6,802 workers across the globe.

What is ICU Medical's official website?

The official website for ICU Medical is http://www.asgn.com.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]


MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  269 (Vote Outperform)
Underperform Votes:  266 (Vote Underperform)
Total Votes:  535
MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2018 by MarketBeat.com Staff

Featured Article: SEC Filing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel